Perrigo Company plc Line of Credit Facility, Maximum Borrowing Capacity
Perrigo Company plc (PRGO) had Line of Credit Facility, Maximum Borrowing Capacity of EUR 1.00 billion as of 2014-12-05, per its 10-KT filed 2016-02-25.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2016-02-25
- 2014-12-05: Line of Credit Facility, Maximum Borrowing Capacity 1.00B EUR.
EUR
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2014-12-05 | 1.00B EUR 10-KT · filed 2016-02-25 |
USD
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2014-11-06 | $1.00B 10-Q · filed 2015-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |